newsfilter
← Latest News
GlobeNewswire·

GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation

MELBOURNE, Australia, March 27, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")) – a global leader in genomics-based tests in health, wellness and serious disease – is